Citing the need to make further improvements in productivity, Novartis has announced plans to eliminate 2,000 jobs globally over the next three to five years and to close two manufacturing sites in Switzerland and one in Italy. The measures were announced with the group’s third-quarter earnings on 25 October 2011.
